CASE DISCUSSION
ECMO in Cardiogenic Shock
Presented India by Dr. V. RakeshViews
8,209
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Extracorporeal membrane oxygenation (ECMO) is a life-support technique used when a person's heart or lungs are severely compromised and cannot provide adequate oxygenation to the body's organs. It involves temporarily diverting a portion of the blood outside the body to a machine that oxygenates it...
Case Summary
- Cardiogenic shock is defined by impaired myocardial performance, leading to decreased cardiac output, organ hypoperfusion, and hypoxia. Diagnostic criteria involve hypotension unresponsive to volume resuscitation, along with evidence of end-organ hypoperfusion such as decreased urine output and altered mental status. Early recognition and intervention are critical due to high mortality rates.
Speaker Profile
Dr. V. Rakesh
HOD, Critical Care and ECMO Specialist, Gemcare Hospitals, HyderabadDr. V. Rakesh is a skilled intensivist and ECMO specialist currently working in Gemcare Hospitals. He is Also the CEO of Varahi Care Services which is a specialized firm offering online service for second opinions on critical care services.
He has demonstrated a history of providing exceptional patient care in fast-paced critical environments. Rakesh\\\'s expertise includes critical care, advanced hemodynamic monitoring, and thoracic organ transplant anesthesia. He serves as a team lead for a 6-bedded CLOSED ECMO ICU, showcasing his leadership abilities. Rakesh is an expert in air transport for critically ill patients and is dedicated to teaching students at various levels. He is recognized for his contributions to medical science, holding two patents, and has received an honorary fellowship from the KALAM INSTITUTE OF HEALTH TECHNOLOGY. His achievements extend to being a national and international level faculty in ECMO training programs and serving as the committee head for research, data, and guidelines for ECMO in India.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.